Novel antituberculosis and antileprotic agents. 1-(3-([5,6,7,8-Tetrahydro-4-(phenylazo- and 3-pyridylazo)-1-naphthyl]amino]propyl)piperidines and related compounds. 1968

L M Werbel, and E F Elslager, and M W Fisher, and Z B Gavrilis, and A A Phillips

UI MeSH Term Description Entries
D007918 Leprosy A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid. Hansen's Disease,Hansen Disease
D008297 Male Males
D010880 Piperidines A family of hexahydropyridines.
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001391 Azo Compounds Organic chemicals where aryl or alkyl groups are joined by two nitrogen atoms through a double bond (R-N Azo Dye,Azo Dyes,Compounds, Azo,Dye, Azo,Dyes, Azo
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

L M Werbel, and E F Elslager, and M W Fisher, and Z B Gavrilis, and A A Phillips
May 2004, Acta crystallographica. Section C, Crystal structure communications,
L M Werbel, and E F Elslager, and M W Fisher, and Z B Gavrilis, and A A Phillips
February 1989, Journal of medicinal chemistry,
L M Werbel, and E F Elslager, and M W Fisher, and Z B Gavrilis, and A A Phillips
May 1985, Journal of medicinal chemistry,
L M Werbel, and E F Elslager, and M W Fisher, and Z B Gavrilis, and A A Phillips
January 1989, Journal of medicinal chemistry,
L M Werbel, and E F Elslager, and M W Fisher, and Z B Gavrilis, and A A Phillips
September 1978, Journal of medicinal chemistry,
L M Werbel, and E F Elslager, and M W Fisher, and Z B Gavrilis, and A A Phillips
January 1971, Journal of the Chemical Society. Perkin transactions 1,
L M Werbel, and E F Elslager, and M W Fisher, and Z B Gavrilis, and A A Phillips
October 1991, Journal of medicinal chemistry,
L M Werbel, and E F Elslager, and M W Fisher, and Z B Gavrilis, and A A Phillips
January 1973, Acta poloniae pharmaceutica,
L M Werbel, and E F Elslager, and M W Fisher, and Z B Gavrilis, and A A Phillips
January 2003, Acta crystallographica. Section C, Crystal structure communications,
L M Werbel, and E F Elslager, and M W Fisher, and Z B Gavrilis, and A A Phillips
January 1985, Arzneimittel-Forschung,
Copied contents to your clipboard!